Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab

We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.

Detalles Bibliográficos
Autores principales: Bowens, Brendan K., Chou, Eva, LaChance, David P., Huynh, James R., Voorhees, Patrick, Do, Thanh C., Shakir, Mohamed K. M., Hoang, Thanh D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/
https://www.ncbi.nlm.nih.gov/pubmed/36415714
http://dx.doi.org/10.1002/ccr3.6621
_version_ 1784833358775189504
author Bowens, Brendan K.
Chou, Eva
LaChance, David P.
Huynh, James R.
Voorhees, Patrick
Do, Thanh C.
Shakir, Mohamed K. M.
Hoang, Thanh D.
author_facet Bowens, Brendan K.
Chou, Eva
LaChance, David P.
Huynh, James R.
Voorhees, Patrick
Do, Thanh C.
Shakir, Mohamed K. M.
Hoang, Thanh D.
author_sort Bowens, Brendan K.
collection PubMed
description We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.
format Online
Article
Text
id pubmed-9675368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96753682022-11-21 Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab Bowens, Brendan K. Chou, Eva LaChance, David P. Huynh, James R. Voorhees, Patrick Do, Thanh C. Shakir, Mohamed K. M. Hoang, Thanh D. Clin Case Rep Case Report We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement. John Wiley and Sons Inc. 2022-11-19 /pmc/articles/PMC9675368/ /pubmed/36415714 http://dx.doi.org/10.1002/ccr3.6621 Text en Published 2022. This article is a U.S. Government work and is in the public domain in the USA. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Bowens, Brendan K.
Chou, Eva
LaChance, David P.
Huynh, James R.
Voorhees, Patrick
Do, Thanh C.
Shakir, Mohamed K. M.
Hoang, Thanh D.
Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title_full Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title_fullStr Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title_full_unstemmed Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title_short Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
title_sort graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/
https://www.ncbi.nlm.nih.gov/pubmed/36415714
http://dx.doi.org/10.1002/ccr3.6621
work_keys_str_mv AT bowensbrendank gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT choueva gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT lachancedavidp gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT huynhjamesr gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT voorheespatrick gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT dothanhc gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT shakirmohamedkm gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab
AT hoangthanhd gravesdiseasecomplicatedbyconcurrentthyroideyediseaseandpretibialmyxedemasuccessfullytreatedwithteprotumumab

Ejemplares similares